AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 15259448
Drug: Dalteparin (subcutaneous)
RxNorm normalized name: dalteparin
DrugBank: Dalteparin (DB06779)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalteparin (subcutaneous)
Trial: 12847065
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of NT-proBNP and creatinine clearance
Trial: 15259448
Drug: Aspirin and
RxNorm normalized name: Aspirin and Caffeine Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin and heparin (or dalteparin)
Trial: 31909725
Drug: iCBT‐I (internet-delivered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iCBT‐I (internet-delivered cognitive behavioral therapy for insomnia)
Trial: 30975977
Drug: Citalopram (SSRI)
DrugBank: Citalopram (DB00215)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Citalopram (SSRI) preceded by pindolol (5-HT1AR antagonist)
Trial: 28540436
Drug: Oral melatonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral melatonin (0.5 mg/kg, max 20 mg)
Trial: 28540436
Drug: Oral midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral midazolam (0.5 mg/kg, max 20 mg)
Trial: 26529076
Drug: 23vPPV vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 23vPPV vaccine administered during pregnancy (at 30-36 weeks gestation)
Trial: 26529076
Drug: 23vPPV vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 23vPPV vaccine administered at birth
Trial: 26529076
Drug: 23vPPV vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 23vPPV vaccine during pregnancy (post-hoc analysis)
Trial: 21540874
Drug: Supplement group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supplement group (28,000 IU vitamin D2 via supplement)
Trial: 10735923
Drug: LAO (lansoprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LAO (lansoprazole 30 mg o.d., amoxycillin 1 g b.d., ornidazole 500 mg b.d.)
Trial: 10735923
Drug: LAC (lansoprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LAC (lansoprazole 30 mg o.d., amoxycillin 1 g b.d., clarithromycin 500 mg b.d.)
Trial: 2869849
Drug: Nifedipine (20,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (20, 40, and 60 mg b.i.d.)
Trial: 2869849
Drug: Hydralazine (25,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydralazine (25, 50, and 100 mg b.i.d.)
Trial: 31981364
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no MTX treatment)
Trial: 31981364
Drug: Dose-response association
RxNorm normalized name: Besponsa
DrugBank: Inotuzumab ozogamicin (DB05889)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Dose-response association
Trial: 30315150
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) add-on therapy (2700 mg/day) for 6 months
Trial: 26921057
Drug: Aripiprazole adjunctive
RxNorm normalized name: Aripiprazole
DrugBank: Aripiprazole (DB01238)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Aripiprazole adjunctive treatment (5 mg/day for 8 weeks)
Trial: 26921057
Drug: Non-adjunctive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-adjunctive treatment (control group)
Trial: 18627322
Drug: Ezetimibe (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe (10 mg/day for 12 weeks)
Trial: 18627322
Drug: Ezetimibe plus
RxNorm normalized name: Ezetimibe
DrugBank: Ezetimibe (DB00973)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ezetimibe plus atorvastatin
Trial: 11832257
Drug: Idoxifene 5
RxNorm normalized name: Idoxene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Idoxifene 5 mg per day
Trial: 11832257
Drug: Idoxifene 10
RxNorm normalized name: Idoxene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Idoxifene 10 mg per day
Trial: 7862181
Drug: Extended treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended treatment with rifampin plus isoniazid for 12 months
Trial: 7862181
Drug: No further
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No further treatment after 6 months for HIV-seronegative patients
Trial: 1789059
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg bromocriptine po
Trial: 7193614
Drug: Clomipramine (Anafranil)
RxNorm normalized name: clomipramine Oral Capsule [Anafranil]
DrugBank: Clomipramine (DB01242)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomipramine (Anafranil) 10 mg daily, with an option to increase to 40 mg
Trial: 30268865
Drug: Transdermal androgen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal androgen (AndroGel; Besins Healthcare, Brussels, Belgium)
Trial: 28198147
Drug: WC, alanine-aminotransferase,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: WC, alanine-aminotransferase, triglycerides/high-density lipoprotein cholesterol, and homeostasis model assessment of insulin resistance
Trial: 21266301
Drug: Fluoxetine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine plus voucher incentives (FV)
Trial: 21266301
Drug: Fluoxetine without
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine without vouchers (F)
Trial: 16952487
Drug: Therapeutic dose
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic dose (10 mg) of diazepam
Trial: 16952487
Drug: Therapeutic dose
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic dose (7.5 mg) of midazolam
Trial: 16952487
Drug: Therapeutic dose
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic dose (50 mg) of ZK253
Trial: 16952487
Drug: Microdose (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microdose (100 microg) of warfarin
Trial: 16952487
Drug: Therapeutic dose
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic dose (5 mg) of warfarin
Trial: 15307692
Drug: Insulin (Group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin (Group B)
Trial: 15307692
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of insulin and Chinese medicine (Group C)
Trial: 11398518
Drug: Prednisone therapy
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisone therapy (duration not exceeding 3 months)
Trial: 11398518
Drug: Prednisone therapy
RxNorm normalized name: Prednisone
DrugBank: Prednisone acetate (DB14646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prednisone therapy (duration 5 years on average)
Trial: 3706623
Drug: 10.0 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10.0 mg/kg metrifonate (2 doses)
Trial: 3706623
Drug: 7.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg/kg metrifonate (2 doses)
Trial: 3706623
Drug: 10.0 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10.0 mg/kg metrifonate (1 dose)
Trial: 29528180
Drug: Caregiver-only adaptation
RxNorm normalized name: ADAPT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caregiver-only adaptation of family-focused treatment (FFT) for 12-15 weeks
Trial: 29528180
Drug: Caregiver-only adaptation
RxNorm normalized name: ADAPT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caregiver-only adaptation of family-focused treatment (FFT)
Trial: 24588066
Drug: Treatment-as-usual only
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment-as-usual only waitlist condition
Trial: 18936595
Drug: Occlusal splint
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occlusal splint (OS) therapy used at nighttime and for 3 hours during daytime for 7 weeks
Trial: 16087791
Drug: Rofecoxib 25
RxNorm normalized name: rofecoxib 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rofecoxib 25 mg twice daily for 1 week
Trial: 12585182
Drug: Chinese herbal
RxNorm normalized name: GINGER 28 mg in 100 mL TOPICAL OIL [Pain Relief Honzo Seika Chinese Herbal Aroma Oil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese herbal medicine (CHM) plus human chorionic gonadotropin and progesterone
Trial: 10352202
Drug: Intradialytic parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradialytic parenteral nutrition (IDPN) with amino acids (AAs)
Trial: 10352202
Drug: Intradialytic parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradialytic parenteral nutrition (IDPN) without amino acids (AAs)
Trial: 10352202
Drug: Intradialytic parenteral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradialytic parenteral nutrition (IDPN) with all three components (AAs, dextrose, lipids)
Trial: 1779314
Drug: Improved ORS
RxNorm normalized name: Improvest
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Improved ORS (20 g maltodextrin, 4 g glycine, 4 g glycyl‐glycine)
Trial: 1811441
Drug: Standard ORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard ORS (WHO formulation containing citrate)
Trial: 6755855
Drug: Bacillus Calmette-Guerin
RxNorm normalized name: BACILLUS CALMETTE-GUERIN VACCINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bacillus Calmette-Guerin (BCG) adjuvant immunotherapy plus conventional therapy
Trial: 6755855
Drug: Bacillus Calmette-Guerin
RxNorm normalized name: BACILLUS CALMETTE-GUERIN VACCINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bacillus Calmette-Guerin (BCG) adjuvant immunotherapy
Trial: 28122783
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid treatment (0.8 mg daily)
Trial: 28122783
Drug: Enalapril alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril alone (10 mg daily)
Trial: 24299323
Drug: Pantoprazole-Mg 40
RxNorm normalized name: pantoprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole-Mg 40 mg once daily
Trial: 12421192
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (TXA) 10 mg/kg given at conclusion of surgery and again 3 hours later
Trial: 17418554
Drug: Budesonide 400
RxNorm normalized name: Budesonide 400 microgram/actuation powder for inhalation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 400 microg twice daily
Trial: 10510140
Drug: Budesonide 1600
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide 1600 microg twice daily
Trial: 11190754
Drug: Budesonide (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (all doses)
Trial: 9674293
Drug: Digoxin 0.25
RxNorm normalized name: digoxin 0.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Digoxin 0.25 mg/day
Trial: 18672986
Drug: 0.6% eucalyptus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.6% eucalyptus extract chewing gum for 12 weeks (90 mg/day)
Trial: 18672986
Drug: 0.4% eucalyptus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4% eucalyptus extract chewing gum for 12 weeks (60 mg/day)
Trial: 16551899
Drug: Milrinone initial
RxNorm normalized name: Milrinone
DrugBank: Milrinone (DB00235)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Milrinone initial dose of 100 or 250 microg/kg
Trial: 16551899
Drug: Continuous IV
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous IV infusion of milrinone at 0.5 microg x kg(‐1) x min(‐1)
Trial: 16551899
Drug: Infusion rate
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Infusion rate of milrinone at 0.2 microg x kg(‐1) x min(‐1)
Trial: 14666758
Drug: Shenmai Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shenmai Injection (SI)
Trial: 14666758
Drug: Routine treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine treatment + SI
Trial: 10700663
Drug: buspirone 0.14
FDA approved: no
EMA approved: no
PMDA approved: no
Description: buspirone 0.14 mg/kg
Trial: 10700663
Drug: buspirone 0.28
FDA approved: no
EMA approved: no
PMDA approved: no
Description: buspirone 0.28 mg/kg
Trial: 1988669
Drug: Caffeine (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (250 mg 3 times daily)
Trial: 31494096
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg AMG 714
Trial: 31494096
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg AMG 714
Trial: 28735698
Drug: Timely treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Timely treatments for ADHD symptoms and additional support for children with lower IQ and from low-income households
Trial: 23770889
Drug: Trampoline exercise
RxNorm normalized name: tramazoline
DrugBank: Tramazoline (DB13064)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trampoline exercise intervention (daily individualized 20-min sessions for 12 weeks)
Trial: 21794162
Drug: Post-test counseling
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-test counseling by trained counselors and monthly home visits by community support agents
Trial: 15215792
Drug: Telmisartan and
RxNorm normalized name: telmisartan and diuretics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan and Ramipril combination
Trial: 11239640
Drug: Extra-amniotic infusion
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extra-amniotic infusion of PGE2 (0.5 microg/mL)
Trial: 11239640
Drug: Extra-amniotic infusion
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extra-amniotic infusion of saline
Trial: 8072387
Drug: Graded doses
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Graded doses of licorice (814 mg glycyrrhizin)
Trial: 8072387
Drug: Graded doses
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Graded doses of licorice (380 mg glycyrrhizin)
Trial: 8072387
Drug: Graded doses
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Graded doses of licorice (217 mg glycyrrhizin)
Trial: 8072387
Drug: Graded doses
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Graded doses of licorice (108 mg glycyrrhizin)
Trial: 2468871
Drug: Nitrendipine (5-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine (5-20 mg b.i.d.)
Trial: 2468871
Drug: Propranolol (40-120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (40-120 mg b.i.d.)
Trial: 22040504
Drug: Lianhuaqingwen capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lianhuaqingwen capsule (LHC)
Trial: 19453758
Drug: Silymarin (140
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silymarin (140 mg three times a day) plus desferrioxamine
Trial: 11471852
Drug: Imidapril 5
RxNorm normalized name: imidapril 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imidapril 5 ‐ 10 mg/day
Trial: 11471852
Drug: Nifedipine SR
RxNorm normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nifedipine SR 20 ‐ 40 mg twice daily
Trial: 3348161
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg ferrous sulfate.kg‐1.d‐1 for 12 weeks
Trial: 23820968
Drug: Sham subcutaneous
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham subcutaneous injection of sterile saline
Trial: 17058517
Drug: Esomeprazole 40
RxNorm normalized name: esomeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 40 mg once daily (n = 90)
Trial: 17058517
Drug: Pantoprazole 40
RxNorm normalized name: pantoprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole 40 mg once daily (n = 90)
Trial: 9716056
Drug: Ciprofloxacin suspension
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin suspension (10 mg/kg every 12 h for 5 days, maximum individual dose 500 mg)
Trial: 9716056
Drug: Pivmecillinam tablets
DrugBank: Pivmecillinam (DB01605)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pivmecillinam tablets (15-20 mg/kg every 8 h for 5 days, maximum individual dose 300 mg)
Trial: 11099086
Drug: Ciprofloxacin suspension
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin suspension
Trial: 9716056
Drug: Pivmecillinam tablets
DrugBank: Pivmecillinam (DB01605)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pivmecillinam tablets
Trial: 7979041
Drug: Displaced view
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Displaced view with inflated implants
Trial: 7979041
Drug: Deflated adjustable
RxNorm normalized name: panthenol
DrugBank: Panthenol (DB11204)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deflated adjustable implants
Trial: 2722728
Drug: cefoxitin sodium
RxNorm normalized name: Cefoxitin Sodium
DrugBank: Cefoxitin (DB01331)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: cefoxitin sodium (30 mg/kg)
Trial: 2722728
Drug: cefmetazole sodium
RxNorm normalized name: Cefmetazole Sodium
DrugBank: Cefmetazole (DB00274)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: cefmetazole sodium (15 mg/kg)
Trial: 2722728
Drug: cefmetazole sodium
RxNorm normalized name: Cefmetazole Sodium
DrugBank: Cefmetazole (DB00274)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: cefmetazole sodium (30 mg/kg)
Trial: 48347
Drug: Hydromorphone 0.5
RxNorm normalized name: HYDROMORPHONE 0.5MG/ML INJ,30ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydromorphone 0.5 mg
Trial: 31307524
Drug: UGSJB granule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UGSJB granule with acupuncture, twice daily
Trial: 31307524
Drug: Placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo with acupuncture, twice daily
Trial: 26135463
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion (cIV) of 160 mg furosemide for 16 h/day (n=15)
Trial: 26135463
Drug: Bolus injections
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus injections (bI) of 80 mg furosemide twice a day (n=14)
Trial: 26135463
Drug: Furosemide plus
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Furosemide plus hypertonic saline solution (HSS) as an infusion for 30 min once a day (n=14)
Trial: 23066720
Drug: Methotrexate (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methotrexate (0.4 mg/kg weekly)
Trial: 23066720
Drug: Acitretin (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acitretin (0.5 mg/kg daily)
Trial: 10855154
Drug: Home-based preoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based preoperative bowel preparation with home care services
Trial: 10855154
Drug: Home-based preoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based preoperative bowel preparation without home care services
Trial: 10855154
Drug: Hospital-based preoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hospital-based preoperative bowel preparation
Trial: 9096986
Drug: Glipizide GITS
RxNorm normalized name: Glipizide
DrugBank: Glipizide (DB01067)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glipizide GITS (5, 20, 40, or 60 mg)
Trial: 9096986
Drug: Glipizide GITS
RxNorm normalized name: Glipizide
DrugBank: Glipizide (DB01067)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glipizide GITS (5, 10, 15, or 20 mg)
Trial: 8467308
Drug: Structured treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured treatment and teaching programme (4 group sessions conducted by paramedical personnel)
Trial: 8467308
Drug: Structured treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured treatment and teaching programme
Trial: 30882137
Drug: Short-course therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-course therapy (median, 9 days; IQR, 8-10)
Trial: 30882137
Drug: Long-course therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-course therapy (median, 16 days; IQR, 14-17)
Trial: 18420531
Drug: Pegloticase 8
RxNorm normalized name: pegloticase 8 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegloticase 8 mg every 2 weeks
Trial: 18420531
Drug: Pegloticase 8
RxNorm normalized name: pegloticase 8 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegloticase 8 mg every 4 weeks
Trial: 24447425
Drug: Pegloticase (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegloticase (both dosing cohorts)
Trial: 22791906
Drug: Oral cannabis
RxNorm normalized name: Medical Cannabis
DrugBank: Medical Cannabis (DB14009)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cannabis extract (CE) 25 mg daily after titration
Trial: 16981900
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg montelukast daily for 6 days
Trial: 16049631
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment and counseling with a self-help guide for 7 weeks